Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
3,165,524
-
Shares change
-
-111,650
-
Total reported value, excl. options
-
$16,935,156
-
Value change
-
-$558,547
-
Put/Call ratio
-
97.89%
-
Number of buys
-
15
-
Number of sells
-
-19
-
Price
-
$5.35
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2018
50 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2018.
XBiotech Inc. - Common Shares, no par value (XBIT) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,165,524 shares
of 33,289,095 outstanding shares and own 9.51% of the company stock.
Largest 10 shareholders include BlackRock Inc. (906,065 shares), VANGUARD GROUP INC (819,920 shares), STATE STREET CORP (316,726 shares), NORTHERN TRUST CORP (214,626 shares), GEODE CAPITAL MANAGEMENT, LLC (169,806 shares), SCHWAB CHARLES INVESTMENT MANAGEMENT INC (88,109 shares), Bank of New York Mellon Corp (61,491 shares), CREDIT SUISSE AG/ (54,824 shares), TIAA CREF INVESTMENT MANAGEMENT LLC (45,676 shares), and ALLIANCEBERNSTEIN L.P. (42,700 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.